Data set for “Safety of Biologics for the treatment of Asthma in children and adolescents: a systematic review”

Our systematic literature search provides no new, unexpected or unique safety profile for biologics used in asthma therapy in children and adolescents compared to descriptions of the respective product labels. Many common AEs occurred across both short-term and long-term studies. These AEs were expected and in line with prior safety information on these drugs. However, the long-term safety of biologics, particularly that of rare or serious conditions, still requires careful monitoring.